loading









  • Our aim is to bring
    efficient and side effect-free
    botanical based treatments
    for chronic conditions

Founding owners







team altea


Saad Harti
President


Saad has started in the financial field, at Arthur Andersen. He later co-founded Altacare, a healthcare busi-
ness development firm active in more than 50 markets. Saad has pioneered medicine access program in
developing countries.
Saad is a co-founder of Legacy and is managing the company.


team altea


Geert Cauwenbergh, Ph.D.
Partner


Geert founded Barrier Therapeutics, a dermatology company in 2001. After bringing Barrier to success it
was acquired by Stiefel in 2008. Prior to founding Barrier, Geert was responsible for the worldwide
research and development of all skin care products for the Johnson & Johnson consumer companies. He is
a board member of several dermatology companies. He has authored more than 100 publications.
Geert is a shareholder of Legacy and acts as strategic and scientific advisor.


team altea


Michel Chretienne, Pharm D.
VP Quality


Michel has served as Pharmaceutical Director and Pharmacist in charge at Hoechst Marion Roussel
(Aventis) until 1999. Michel is involved in a number of professional and scientific societies such as the
French Association of Regulatory Affairs, Member of the Ethic Committee and Mediation of the French
pharmaceutical industry (CEMIP) etc.
Michel is responsible of the quality and manufacturing affairs of Legacy.


Find us



map

To serve you better, we are present in Europe, Japan, Korea and the US.


Switzerland office
Rte de la Corniche 3B
1066 Epalinges (Lausanne)
Tel +41 21 552 21 70

Email: contact@legacyhealthcare.ch

Japan office
TOC Daiichi Bldg. 6F
1-8-3 Shibuya, Shibuya-ku, Tokyo 150-0002
Tel: +81 3-6805-0651

Email: contact.jp@legacyhealthcare.ch

Korea office
Kyobo Building, CEO Suite
15th Floor, 1 Jongno, Jongno-gu,
Seoul 110-714, South Korea
Tel: +82 2 741 3171

Email: contact.kr@legacyhealthcare.ch

USA office
1 Stults Drive,
Plainsboro, New Jersey 08536

Email: contact.usa@legacyhealthcare.ch
We develop products where options are limited



Pre-clinical
Clinical
Market
Androgenetic Alopecia (AGA & FPHL)
Chemotherapy Induced Alopecia (CIA)
Persistent Chemotherapy Induced Alopecia (PCIA)
Alopecia Areata in children (AA)
Cancer Related Fatigue (CRF)
Our work was presented at major scientific congresses.


AGA
CIA / PCIA

2016 - AAD
American Academy of Dermatology - USA

2016 - MASCC
Multinational Association Supportive Care Cancer - Australia
2016 - EADV
European Academy of Dermatology & Venereology - Greece
2016 - AACR
American Association for Cancer Research - USA
2015 - EADV
European Academy of Dermatology & Venereology - Denmark
2015 - MASCC
Multinational Association for Supportive Care in Cancer - USA
2014 - Singapore International Conference on Skin Research
Singapore
2015 - AACR
American Association for Cancer Research - USA
2014 - AAD
American Academy of Dermatology - USA
2015 - NCBC
National Consortium of Breast Centers - USA
2014 - EADV
European Academy of Dermatology & Venereology - Serbia
2015 - YSC
Young Survival Coalition - USA
2014 - WCHR
World Congress for Hair Research - Korea
2015 - ONS
Oncology Nursing Society - USA
2013 - EADV
European Academy of Dermatology & Venereology - Turkey
2014 - SABCS
San Antonio Breast Cancer Symposium - USA
2013 - WCHR
World Congress for Hair Research - Scotland
2014 - Critical Mass
Young Adult Cancer Alliance - USA
2012 - ISHRS
International Society for Hair Restoration Surgery - The Bahamas
2014 - SIO
Society of Integrative Oncology - USA
2012 - JSCHR
Japan Society of Clinical Hair Restoration - Japan
2014 - SIS
World Congress on Breast Cancer - USA
2014 - AACR
American Association for Cancer Research - USA
2014 - MASCC
Multinational Association for Supportive Care in Cancer - USA
2013 - AACR
American Association for Cancer Research - USA
2013 - MASCC
Multinational Association for Supportive Care in Cancer - USA

Copyright © 2016 Legacy Healthcare / All rights reserved.